For the first time in over 60 years, and just in time for summer, the FDA approved an exciting new product for spider veins called Asclera™ (polidocanol) Injection from Merz Aesthetics. Polidocanol has been widely used in Europe for many years, but this is the first time it has come to American shores.
Asclera can treat thread veins of less than 1 mm in diameter and uncomplicated and small varicose veins from 1 to 3 mm in diameter from the thighs down. Once injected, Asclera™ works by damaging the cell lining of blood vessels, causing them to collapse right before your eyes. The advantages of this solution over many of the other commonly used vein solutions is that doctors remark that it takes the sting out of sclerotherapy and is much easier to tolerate – plus it seems to work better too.
According to New York Plastic Surgeon Dr. Jeffrey Yager, Founder of Yager Esthetics; “I look forward to offering Asclera to my patients. It will be a welcome addition to our cosmetic surgery center and medspa because it has been proven to be an effective, predictable and affordable treatment for spider veins.”
Ask about Aesclera at dermatologists and cosmetic surgeons offices in July 2010.